1,410
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials

, , , , , & , MD show all
Pages 301-310 | Received 30 Mar 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stefano Marventano, Paulina Kolacz, Sabrina Castellano, Fabio Galvano, Silvio Buscemi, Antonio Mistretta & Giuseppe Grosso. (2015) A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio really matter?. International Journal of Food Sciences and Nutrition 66:6, pages 611-622.
Read now
Andy H Lee & Naoko Hiramatsu. (2011) Role of n-3 series polyunsaturated fatty acids in cardiovascular disease prevention. Nutrition and Dietary Supplements 3, pages 93-100.
Read now

Articles from other publishers (60)

Mohammad A. Alfhili, Jawaher Alsughayyir, Ahmed Basudan, Mohammed Alfaifi, Zuhier A. Awan, Mohammed R. Algethami & Yazeed A. Al-Sheikh. (2023) Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia. Saudi Journal of Biological Sciences 30:3, pages 103577.
Crossref
Ivana Djuricic & Philip C. Calder. (2023) Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health. Annual Review of Pharmacology and Toxicology 63:1, pages 383-406.
Crossref
Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis & Helen Melita. (2022) Diet and Sudden Death: How to Reduce the Risk. Current Vascular Pharmacology 20:5, pages 383-408.
Crossref
Austin Angelotti, Deena B. Snoke, Kate Ormiston, Rachel M. Cole, Kamil Borkowski, John W. Newman, Tonya S. Orchard & Martha A. Belury. (2022) Potential Cardioprotective Effects and Lipid Mediator Differences in Long-Chain Omega-3 Polyunsaturated Fatty Acid Supplemented Mice Given Chemotherapy. Metabolites 12:9, pages 782.
Crossref
Dimitrios Tsartsalis, Dafni Korela, Lars O. Karlsson, Emmanouil Foukarakis, Anneli Svensson, Aris Anastasakis, Dimitrios Venetsanos, Constantina Aggeli, Costas Tsioufis, Frieder Braunschweig, Elena Dragioti & Emmanouil Charitakis. (2022) Risk and Protective Factors for Sudden Cardiac Death: An Umbrella Review of Meta-Analyses. Frontiers in Cardiovascular Medicine 9.
Crossref
A. V. Susekov. (2021) Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis. Kardiologiia 61:6, pages 88-96.
Crossref
Maria Luz Fernandez, Sarah A. Blomquist, Brian Hallmark & Floyd H. Chilton. (2021) Omega-3 Supplementation and Heart Disease: A Population-Based Diet by Gene Analysis of Clinical Trial Outcomes. Nutrients 13:7, pages 2154.
Crossref
Asmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, Priti Biswas, Gabrielle C Thorpe, Helen J Moore, Katherine HO Deane, Carolyn D Summerbell, Helen V Worthington, Fujian Song & Lee Hooper. (2020) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Jacqueline K. Innes & Philip C. Calder. (2020) Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020. International Journal of Molecular Sciences 21:4, pages 1362.
Crossref
John Nowicki, Cristiana I. Paul, Alexander G. Schauss & Joseph E. Pizzorno. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine 593 612.e8 .
Sho-ichi Yamagishi & Takanori Matsui. (2019) Effects of Dietary Intake and Supplementation of Fatty Acids on Cardiometabolic Disorders in Humans: a Lesson from a Large Number of Meta-Analyses. Letters in Drug Design & Discovery 16:10, pages 1138-1145.
Crossref
Philip C. Calder & Richard J. Deckelbaum. (2019) Editorial. Current Opinion in Clinical Nutrition & Metabolic Care 22:2, pages 97-102.
Crossref
Nicholas L. DePace & Joseph ColomboNicholas L. DePace & Joseph Colombo. 2019. Clinical Autonomic and Mitochondrial Disorders. Clinical Autonomic and Mitochondrial Disorders 37 70 .
Asmaa S Abdelhamid, Tracey J Brown, Julii S Brainard, Priti Biswas, Gabrielle C Thorpe, Helen J Moore, Katherine HO Deane, Fai K AlAbdulghafoor, Carolyn D Summerbell, Helen V Worthington, Fujian Song & Lee Hooper. (2018) Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews.
Crossref
Trevor A. Mori. (2018) Reprint of: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease. Fitoterapia 126, pages 8-15.
Crossref
Kazuo Yamagata. (2017) Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. Lipids in Health and Disease 16:1.
Crossref
Trevor A. Mori. (2017) Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease. Fitoterapia 123, pages 51-58.
Crossref
Manjir Kataki, Ananya Rajkumari & Bhaskar Mazumder. 2017. Nutrigenomics and Nutraceuticals. Nutrigenomics and Nutraceuticals 451 482 .
Masayuki Takamura, Keisuke Kurokawa, Hiroshi Ootsuji, Oto Inoue, Hikari Okada, Ayano Nomura, Shuichi Kaneko & Soichiro Usui. (2017) Long‐Term Administration of Eicosapentaenoic Acid Improves Post–Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization. Journal of the American Heart Association 6:2.
Crossref
Xianxing Xie, Tao Zhang, Shuang Zhao, Wei Li, Lanzhi Ma, Ming Ding & Yuan Liu. (2016) Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats. Lipids in Health and Disease 15:1.
Crossref
Susan Sergeant, Elaheh Rahbar & Floyd H. Chilton. (2016) Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. European Journal of Pharmacology 785, pages 77-86.
Crossref
Ankur Sethi, Anurag Bajaj, Sandeep Khosla & Rohit R. Arora. (2016) Statin Use Mitigate the Benefit of Omega-3 Fatty Acids Supplementation—A Meta-Regression of Randomized Trials. American Journal of Therapeutics 23:3, pages e737-e748.
Crossref
J. R. Lupton, J. B. Blumberg, M. L?Abbe, M. LeDoux, H. B. Rice, C. von Schacky, A. Yaktine & J. C. Griffiths. (2016) Nutrient reference value: non-communicable disease endpoints?a conference report. European Journal of Nutrition 55:S1, pages 1-10.
Crossref
Terry A. Jacobson, Kevin C. Maki, Carl E. Orringer, Peter H. Jones, Penny Kris-Etherton, Geeta Sikand, Ralph La Forge, Stephen R. Daniels, Don P. Wilson, Pamela B. Morris, Robert A. Wild, Scott M. Grundy, Martha Daviglus, Keith C. Ferdinand, Krishnaswami Vijayaraghavan, Prakash C. Deedwania, Judith A. Aberg, Katherine P. Liao, James M. McKenney, Joyce L. Ross, Lynne T. Braun, Matthew K. Ito, Harold E. Bays & W. Virgil Brown. (2015) National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. Journal of Clinical Lipidology 9:6, pages S1-S122.e1.
Crossref
Karen R. Sando & Michelle Knight. (2015) Nonstatin Therapies for Management of Dyslipidemia: A Review. Clinical Therapeutics 37:10, pages 2153-2179.
Crossref
Paul Nestel, Peter Clifton, David Colquhoun, Manny Noakes, Trevor A. Mori, David Sullivan & Beth Thomas. (2015) Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease. Heart, Lung and Circulation 24:8, pages 769-779.
Crossref
Richard Kones & Umme Rumana. (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 75:11, pages 1201-1228.
Crossref
Jennifer E Enns, Azadeh Yeganeh, Ryan Zarychanski, Ahmed M Abou-Setta, Carol Friesen, Peter Zahradka & Carla G Taylor. (2014) The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysis. BMC Cardiovascular Disorders 14:1.
Crossref
Masayuki Doi, Kazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, Masahito Kajiya, Keisuke Okawa, Rie Nakayama, Wataru Takagi, Ko Takeda, Satoshi Hirohata & Hiroshi Ito. (2014) Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study. International Journal of Cardiology 176:3, pages 577-582.
Crossref
Barak Zafrir & Mohit Jain. (2014) Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications. Cardiovascular Drugs and Therapy 28:4, pages 361-377.
Crossref
Peter L. McLennan. (2014) Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. European Journal of Applied Physiology 114:7, pages 1333-1356.
Crossref
Subrata Kar. (2014) Omacor and Omega-3 Fatty Acids for Treatment of Coronary Artery Disease and the Pleiotropic Effects. American Journal of Therapeutics 21:1, pages 56-66.
Crossref
Trevor A. Mori. (2014) Omega-3 fatty acids and cardiovascular disease: epidemiology and effects on cardiometabolic risk factors. Food Funct. 5:9, pages 2004-2019.
Crossref
Roberto Marchioli & Giacomo Levantesi. (2013) n?3 PUFAs in cardiovascular disease. International Journal of Cardiology 170:2, pages S33-S38.
Crossref
George E. Billman. (2013) The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: A critical reassessment. Pharmacology & Therapeutics 140:1, pages 53-80.
Crossref
Claudio Bilato. (2013) n-3 Fatty acids and cardiovascular disease: the story is not over yet. Aging Clinical and Experimental Research 25:4, pages 357-363.
Crossref
Wei Xin, Wei Wei & Xiao-Ying Li. (2013) Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition 97:5, pages 926-935.
Crossref
William S. Harris. (2013) Are n-3 fatty acids still cardioprotective?. Current Opinion in Clinical Nutrition and Metabolic Care 16:2, pages 141-149.
Crossref
Su Mi Lee & Won Suk An. (2013) Cardioprotective Effects of ω -3 PUFAs in Chronic Kidney Disease . BioMed Research International 2013, pages 1-8.
Crossref
Richard Glickman-Simon & Alan Ehrlich. (2013) Omega-3 Supplementation and Cardiovascular Disease, Acupuncture and Chronic Obstructive Pulmonary Disease (COPD), Myofascial Physical Therapy and Interstitial Cystitis, and Yoga and Chronic Pain. EXPLORE 9:1, pages 54-57.
Crossref
Joseph E. Pizzorno, Cristiana Paul & Alexander G. Schauss. 2013. Textbook of Natural Medicine. Textbook of Natural Medicine 745 771 .
R. Sharma, R.J. Moffatt, R.B. Singh & J. Katz. 2013. Bioactive Food as Dietary Interventions for Cardiovascular Disease. Bioactive Food as Dietary Interventions for Cardiovascular Disease 1 28 .
R. Sharma. 2013. Bioactive Food as Dietary Interventions for Cardiovascular Disease. Bioactive Food as Dietary Interventions for Cardiovascular Disease 465 489 .
. (2012) n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia. New England Journal of Medicine 367:4, pages 309-318.
Crossref
George E. BillmanCynthia A. CarnesPhilip B. AdamsonEmilio VanoliPeter J. Schwartz. (2012) Dietary Omega-3 Fatty Acids and Susceptibility to Ventricular Fibrillation. Circulation: Arrhythmia and Electrophysiology 5:3, pages 553-560.
Crossref
D. Kromhout, S. Yasuda, J. M. Geleijnse & H. Shimokawa. (2011) Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?. European Heart Journal 33:4, pages 436-443.
Crossref
Jian Shen. (2011) Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Reality or Mirage?. Current Cardiovascular Risk Reports 6:1, pages 21-26.
Crossref
Hosen KiatYu Sun BinSuzanne GrantDennis Hsu‐Tung Chang. (2011) Complementary medicine use in cardiovascular disease: a clinician's viewpoint. Medical Journal of Australia 195:11-12, pages 654-656.
Crossref
Qi Chen, Liu-Quan Cheng, Tie-Hui Xiao, Yu-Xiao Zhang, Mei Zhu, Ran Zhang, Ke Li, Yu Wang & Yang Li. (2011) Effects of Omega-3 Fatty Acid for Sudden Cardiac Death Prevention in Patients with Cardiovascular Disease: A Contemporary Meta-Analysis of Randomized, Controlled Trials. Cardiovascular Drugs and Therapy 25:3, pages 259-265.
Crossref
Gustav Dobos & Iven Tao. (2011) The model of western integrative medicine: The role of Chinese medicine. Chinese Journal of Integrative Medicine 17:1, pages 11-20.
Crossref
Bernhard RauchRudolf SchieleSteffen SchneiderFrank DillerNorbert VictorHelmut GohlkeMartin GottwikGerhard SteinbeckUlrike Del CastilloRudolf SackHeinrich WorthHugo KatusWilhelm SpitzerGeorg SabinJochen Senges. (2010) OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction. Circulation 122:21, pages 2152-2159.
Crossref
Giuseppe Boriani, Igor Diemberger, Cinzia Valzania, Mauro Biffi, Cristian Martignani, Emanuel Raschi, Valentina Mantovani, Matteo Ziacchi, Matteo Bertini, Fabrizio De Ponti & Angelo Branzi. (2010) Role of drugs and devices in patients at risk of sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, pages 575-594.
Crossref
Naranjan S. Dhalla, Adriana Adameova & Meera Kaur. (2010) Role of catecholamine oxidation in sudden cardiac death. Fundamental & Clinical Pharmacology 24:5, pages 539-546.
Crossref
Ameer Y. Taha, W. McIntyre Burnham & Stéphane Auvin. (2010) Polyunsaturated fatty acids and epilepsy. Epilepsia 51:8, pages 1348-1358.
Crossref
Brad McEwen, Marie-Christine Morel-Kopp, Geoffrey Tofler & Christopher Ward. (2010) Effect of Omega-3 Fish Oil on Cardiovascular Risk in Diabetes. The Diabetes Educator 36:4, pages 565-584.
Crossref
George E. BillmanYoshinori Nishijima, Andriy E. BelevychDmitry TerentyevYing XuKaylan M. HaizlipMichelle M. MonaskyNitisha HiranandaniWilliam S. Harris, Sandor GyorkeCynthia A. Carnes & Paul M. L. Janssen. (2010) Effects of dietary omega–3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. American Journal of Physiology-Heart and Circulatory Physiology 298:4, pages H1219-H1228.
Crossref
. (2010) Current World Literature. Current Opinion in Clinical Nutrition & Metabolic Care 13:2, pages 215-221.
Crossref
Gustav Dobos. (2009) Integrative Medicine – Medicine of the future or ‘Old Wine in New Skins’?. European Journal of Integrative Medicine 1:3, pages 109-115.
Crossref
John G.T. Augoustides & Prakash Patel. (2009) Recent Advances in Perioperative Medicine: Highlights From the Literature for the Cardiothoracic and Vascular Anesthesiologist. Journal of Cardiothoracic and Vascular Anesthesia 23:3, pages 430-436.
Crossref
Robert K. McNamara. (2009) Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder. Cardiovascular Psychiatry and Neurology 2009, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.